Call: (+91) 73979 11126
Name : Lonitab Composition : Minoxidil Manufactured by : Intas Pharmaceuticals Ltd Strength: 2.5mg, Packing : 3×10 Tablets (Per Pack)
Lonitab 2.5 Tablet belongs to a class of drugs known as vasodilators. It is used in the treatment of hair loss. It slows down the progression of hair loss. This medicine promotes hair growth by increasing the blood flow to hair follicles by widening the blood vessels.
In Treatment of Hair loss Lonitab Tablet is a medicine used to treat common hereditary hair loss. It can prevent further hair loss and help hair to re-grow. It works by increasing blood flow to the hair follicles on your scalp, which prevents hair cell death and also enhances new hair growth. It is most effective for baldness or thinning at the top of the scalp but less effective at the front or for receding hairline.
Benefits are less likely if you have been bald for many years or have a large area of hair loss. Lonitab Tablet is not suitable for sudden or unexplained hair loss. It is considered a safe medicine. There are separate products for men and women and you should follow your doctor’s instructions carefully while using Lonitab Tablet. Regrowth of hair improves your appearance, boosts your confidence, and enhances your social life. Use it regularly to maintain hair growth and to get the maximum benefits. Consult your doctor if you notice any changes in the hair growth while using Lonitab Tablet.
Lonitab Tablet belongs to the class of medicine known as pottasium channel openers. It is an antihypertensive peripheral vasodilator. It works by opening adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells. This helps to dilate the arteries (blood vessels) to increase the blood flow and to decrease the blood pressure.
Product Enquiry
Select you countryAfghanistanAlbaniaAlgeriaAndorraAngolaAntigua and BarbudaArgentinaArmeniaAustraliaAustriaAzerbaijanThe BahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBruneiBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCentral African RepublicChadChileChinaColombiaComorosCongoCosta RicaCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFijiFinlandFranceGabonThe GambiaGeorgiaGermanyGhanaGreeceGrenadaGuatemalaGuineaGuinea-BissauGuyanaHaitiHondurasHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyamaicaJapanJordanKazakhstanKenyaKiribatiKorea, NorthKorea, SouthKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew ZealandNicaraguaNigerNigeriaNorth MacedoniaNorwayOmanPakistanPalauPanamaPapua New GuineaParaguayPeruPhilippinesPolandPortugalQatarRomaniaRussiaRwandaSaint Kitts and NevisSaint LuciaSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSpainSri LankaSudanSudan, SouthSurinameSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamYemenZambiaZimbabwe
Log in